The n-Lorem Foundation operates with an unwavering commitment to addressing the unique needs of patients afflicted by nano-rare diseases stemming from single gene mutations, affecting fewer than 30 individuals worldwide with the same genetic anomaly. Recognizing the limitations of commercial models in catering to the exceptional circumstances of these patients, the foundation leverages the remarkable efficiency, versatility, and cost-effectiveness of Antisense Oligonucleotide (ASO) technology to provide free, lifelong treatment.
Their resolute non-profit approach ensures that these nano-rare patients, who would otherwise face exorbitant costs, receive the care they require. This groundbreaking initiative, supported by a seasoned leadership team and strategic partnerships, offers hope and access to experimental ASO treatments for those whose conditions fall within their purview, bringing optimism and much-needed relief to those facing these extraordinary medical challenges.
Their resolute non-profit approach ensures that these nano-rare patients, who would otherwise face exorbitant costs, receive the care they require. This groundbreaking initiative, supported by a seasoned leadership team and strategic partnerships, offers hope and access to experimental ASO treatments for those whose conditions fall within their purview, bringing optimism and much-needed relief to those facing these extraordinary medical challenges.
MAKE CONTACT
